Zobrazeno 1 - 10
of 22
pro vyhledávání: '"P. C. L. Choi"'
Autor:
Chandu Sadasivan, Josie T Y Chow, Bun Sheng, David K H Chan, Yiting Fan, Paul C L Choi, Jeffrey K T Wong, Mabel M B Tong, Tsz-Ngai Chan, Erik Fung, Kevin K H Kam, Joseph Y S Chan, Wai-Kin Chi, D Ian Paterson, Manohara Senaratne, Neil Brass, Gavin Y Oudit, Alex P W Lee
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239675 (2020)
Fabry Disease (FD) is a systemic disorder that can result in cardiovascular, renal, and neurovascular disease leading to reduced life expectancy. FD should be considered in the differential of all patients with unexplained left ventricular hypertroph
Externí odkaz:
https://doaj.org/article/d710dc75f1be46ac9b0429cca5766eb1
Autor:
Siu Ying Angel Nip, Kam Lun Hon, Wing Kwan Alex Leung, Alexander K. C. Leung, Paul C. L. Choi
Publikováno v:
Case Reports in Pediatrics, Vol 2016 (2016)
Hemangioma is the most common vascular tumor of infancy; presentation is often as cutaneous infantile hemangioma (IH). Cutaneous hemangioma is a clinical diagnosis. Most IHs follow a benign course, with complete involution without treatment in the ma
Externí odkaz:
https://doaj.org/article/0f4882b4cdb44900925a19de67cb2990
Autor:
Ka Tak Wong, P. C.-L. Choi, Bun Sheng, Alex Pui-Wai Lee, Kevin Ka-Ho Kam, Josie Tsz ying Chow, Joseph Ys Chan, Tong Mei Po Mabel, Yiting Fan, Tsz Ngai Chan, Wai Kin Chi, Erik Fung
Publikováno v:
Circulation. 142
Introduction: The genetic mutation IVS4+919G>A commonly found among Chinese is associated with later-onset cardiac variant of Fabry disease (FD). Patients with left ventricular hypertrophy (LVH) may be screened for FD by measuring plasma α-galactosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19055e3b754a286231b9651fc4256e3f
https://doi.org/10.1161/circ.142.suppl_3.13424
https://doi.org/10.1161/circ.142.suppl_3.13424
Autor:
J. Pang, W. Xu, P. C.-L. Choi, V. W.-S. Wong, Xiang Zhang, Grace Lai-Hung Wong, Anthony W.H. Chan, Hung Chan, Jun Yu, Sally She-Ting Shu, Hoi-Yun Chan, Chi-Hang Tse
Publikováno v:
Alimentary Pharmacology & Therapeutics. 46:175-182
Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97e97074fb135854d0b176f52419d3cd
https://doi.org/10.1111/apt.14119
https://doi.org/10.1111/apt.14119
Autor:
P. C.-L. Choi, V. W.-S. Wong, Anthony W.H. Chan, Chi-Hang Tse, Grace Lai-Hung Wong, Zhuo Yu, Angel Mei-Ling Chim, Hung Chan, Hoi-Yun Chan
Publikováno v:
Alimentary Pharmacology & Therapeutics. 39:883-893
Summary Background Metabolic syndrome is a known risk factor of cirrhosis in chronic hepatitis B (CHB). Aim To investigate the effects of coincidental metabolic syndrome on liver fibrosis progression in treatment-naive CHB patients. Methods A total o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7927c78eeda543874d32848243634e2a
https://doi.org/10.1111/apt.12658
https://doi.org/10.1111/apt.12658
Autor:
Jiayun Shen, P. C.-L. Choi, David K.W. Yeung, Anthony W.H. Chan, V. W.-S. Wong, Winnie C.W. Chu, Angel Mei-Ling Chim, Hoi-Yun Chan, Ruth Chan, Hung Chan, Jean Woo, Grace Lai-Hung Wong
Publikováno v:
Alimentary Pharmacology & Therapeutics. 39:532-539
Summary Background The rs738409 GG variant in patatin-like phospholipase 3 (PNPLA3) is associated with non-alcoholic fatty liver disease (NAFLD) and disease severity. However, it remains unclear if it contributes to the development of NAFLD through a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25093d6c02b5d7b5348103782303d2d9
https://doi.org/10.1111/apt.12609
https://doi.org/10.1111/apt.12609
Autor:
P. C.-L. Choi, Angel Mei-Ling Chim, Grace Lai-Hung Wong, Hung Chan, Jun Yu, V. W.-S. Wong, Jiayun Shen, David K.W. Yeung, Winnie C.W. Chu, Anthony W.H. Chan, Hoi-Yun Chan
Publikováno v:
Alimentary Pharmacology & Therapeutics. 36:1057-1066
Summary Background The diagnosis of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and fibrosis relies on liver biopsy. Non-invasive assessments are urgently needed. Aim To evaluate cell apoptotic marker cytokeratin-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc1cd0a924e1003211f60bcd181169d6
https://doi.org/10.1111/apt.12091
https://doi.org/10.1111/apt.12091
Publikováno v:
Alimentary Pharmacology & Therapeutics. 31:1095-1103
Aliment Pharmacol Ther 31, 1095–1103 Summary Background Non-invasive assessments of liver fibrosis in chronic hepatitis B were well established. Aim To develop a combined algorithm of liver stiffness measurement (LSM) and serum test formula to pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::493d7b0f70371f5d89a4c13c523f3570
https://doi.org/10.1111/j.1365-2036.2010.04276.x
https://doi.org/10.1111/j.1365-2036.2010.04276.x
Autor:
Anthony W.H. Chan, Hung Chan, V. W.-S. Wong, Grace Lai-Hung Wong, Angel Mei-Ling Chim, P. C.-L. Choi, Francis K.L. Chan, S W C Tsang, Joseph J.Y. Sung, Alex Yui Hui, Shirley Ho-Ting Chu
Publikováno v:
Alimentary Pharmacology & Therapeutics. 29:387-396
Summary Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in affluent countries. Serum alanine aminotransferase (ALT) level is commonly performed to monitor NAFLD patients, but its clinical relevance is unc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0831b2c872270d6a3033d1e136ed75d5
https://doi.org/10.1111/j.1365-2036.2008.03896.x
https://doi.org/10.1111/j.1365-2036.2008.03896.x
Publikováno v:
Hong Kong medical journal = Xianggang yi xue za zhi. 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a64b509bf15b1b77478f9d9ace2885bd
https://pubmed.ncbi.nlm.nih.gov/25482969
https://pubmed.ncbi.nlm.nih.gov/25482969